VERSEAU THERAPEUTICS

Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.

#SimilarOrganizations #People #Financial #Event #Website #More

VERSEAU THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Therapeutics

Founded:

2017-01-01

Address:

Bedford, Massachusetts, United States

Country:

United States

Website Url:

http://www.verseautx.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

54.3 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

bicara-therapeutics-logo

Bicara Therapeutics

Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

stoke-therapeutics-logo

Stoke Therapeutics

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.

Current Employees Featured

karen-tubridy_image

Karen Tubridy
Karen Tubridy Chief Development Officer @ Verseau Therapeutics
Chief Development Officer
2021-01-01

john-edwards_image

John Edwards
John Edwards CEO @ Verseau Therapeutics
CEO
2020-01-01

daniel-anderson_image

Daniel Anderson
Daniel Anderson Co-Founder @ Verseau Therapeutics
Co-Founder
2017-03-01

tatiana-novobrantseva_image

Tatiana Novobrantseva
Tatiana Novobrantseva Co-founder & Chief Scientific Officer @ Verseau Therapeutics
Co-founder & Chief Scientific Officer
2019-03-01

robert-langer_image

Robert Langer
Robert Langer Co-Founder @ Verseau Therapeutics
Co-Founder
2017-03-01

igor-feldman_image

Igor Feldman
Igor Feldman Co-founder @ Verseau Therapeutics
Co-founder
2017-01-01

Founder

daniel-anderson_image

Daniel Anderson

igor-feldman_image

Igor Feldman

robert-langer_image

Robert Langer

tatiana-novobrantseva_image

Tatiana Novobrantseva

Investors List

alexandria-venture-investments_image

Key Employee Changes

Date	New article
2021-09-07	Verseau Therapeutics Appoints Karen Tubridy as Chief Development Officer
2021-05-26	Biotech flipper John Edwards joins Verseau as CEO after overseeing Tilos from birth to Merck buy

Official Site Inspections

http://www.verseautx.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.59 K

Host Informations
Whois Informations

Loading ...